Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Benevir Biopharm Inc.

Headquarters: Rockville, MD, United States of America
Website: N/A
Year Founded: 2011
Status: Acquired

BioCentury | Dec 3, 2021
Product Development

Dec. 2 Quick Takes: $109M series C for Acepodia

Plus Tune catches $40M series A from NEA, Emerson, and Astellas-Dyno, Omeros, Vir and more
BioCentury | Nov 16, 2021
Data Byte

The oncolytic virus pipeline

At least 49 oncolytic virus therapies now in development behind the sole FDA-approved product
BioCentury | Jul 12, 2018
Product R&D

All-in-one viruses

How PsiOxus is building a gene therapy cancer platform on its oncolytic virus
BioCentury | May 4, 2018
Company News

Janssen grabs up oncolytic virus company BeneVir

BioCentury | Feb 29, 2016
Financial News

BeneVir financial update

BioCentury | Nov 24, 2014
Financial News

BeneVir completes venture financing

Items per page:
1 - 7 of 7
Help Center
Username
Request a Demo
Request Training
Ask a Question